LOGIN  |  REGISTER
Viking Therapeutics
Amneal Pharmaceuticals

Quest Diagnostics Provides No-Cost Wellness Testing to Underserved Black Community in the Bronx

November 29, 2022 | Last Trade: US$163.59 0.30 -0.18

NORTHAMPTON, MA / ACCESSWIRE / November 29, 2022 / Choose Healthy Life (CHL) is a sustainable, scalable, and transferable approach to addressing public health disparities and inequities in the Black community by establishing a health workforce in the Black church. CHL began with 50 churches in 5 cities and expanded last year to 120 churches in 13 states and the District of Columbia. As a founding sponsor, the Quest Diagnostics Foundation provided financial support to establish CHL's church-based community health workforce.

GreenStockNews

Quest Diagnostics and the Quest Foundation, through the Quest for Health Equity initiative, are building on our initial commitment to CHL through its support of CHL's Community Wellness Program by offering Blueprint for Wellness®. This comprehensive health screening provides a clinical set of laboratory tests and measurements completed to highlight personal health strengths and risks that will support underserved communities in taking control of their health.

Quest recently attended one of CHL's community health events in the Bronx, New York, and provided no-cost Blueprint for Wellness® to 69 attendees from the community. The event included a network of resources including flu shots, COVID-19 boosters, and a winter coat drive distribution of coats, hats, scarfs, and gloves to over 300 people.

Several Quest employees volunteered their time to support this important community event including Chief Human Resources Officer Cecilia McKenney.

To learn more about Choose Healthy life, visit www.choosehealthylife.org

View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com.

Contact Info:
Spokesperson: Quest Diagnostics
Website: http://www.questdiagnostics.com
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Viking Therapeutics

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB